Jaguar Health JAGX
NASDAQ JAGX
$0.44 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Jaguar Health (JAGX) Non-Current Deferred Tax Liability (2017 - 2019)

Updated

Jaguar Health (JAGX) reported Non-Current Deferred Tax Liability of $20,594 for Q4 2019.

Analysis

Jaguar Health (JAGX) Non-Current Deferred Tax Liability (2017 - 2019) Analysis & Trends

  • The Q4 2019 figure ranks as the highest quarterly Non-Current Deferred Tax Liability since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Jaguar Health 70,422.88 -17.18 Mn 194,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 20,594.00
Sep 30, 2017 990,549.00
API Access

Jaguar Health Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=JAGX&period=max&api_key=YOUR_API_KEY